Search - tctmd.com

Displaying 21 - 40 of 3243

Sort: Relevancy | Date

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

News Daily News

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

Yael L. Maxwell

December 09, 2025

RSV Infection Ups CV Risk for Older Adults, Albeit With Some Heterogeneity

News Daily News

RSV Infection Ups CV Risk for Older Adults, Albeit With Some Heterogeneity

Yael L. Maxwell

December 08, 2025

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

News Daily News

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

Yael L. Maxwell

December 05, 2025

Frailty Extra Risky in Young Patients With Acute MI

News Daily News

Frailty Extra Risky in Young Patients With Acute MI

December 04, 2025

Reversal of Childhood Overweight May Prevent Later CHD Risks

News Daily News

Reversal of Childhood Overweight May Prevent Later CHD Risks

December 03, 2025

November 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

November 24, 2025

Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis

News Daily News

Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis

November 21, 2025

High Adolescent BP Tied to Subclinical Disease in Middle Age

News Daily News

High Adolescent BP Tied to Subclinical Disease in Middle Age

Michael O'Riordan

November 20, 2025

News Industry News

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

November 19, 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

News Conference News AHA 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Michael O'Riordan

November 14, 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

News Conference News AHA 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

November 08, 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

November 08, 2025

Heavy Alcohol Use Tied to More-Severe Intracerebral Hemorrhages

News Daily News

Heavy Alcohol Use Tied to More-Severe Intracerebral Hemorrhages

November 06, 2025

‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains

News Conference News TCT 2025

‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains

Yael L. Maxwell

November 05, 2025

What’s Going to Be Hot at AHA 2025?

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2025

TCT 1765: Ostial Left Main CTO Impella-Assisted Intervention in An 80-Year-Old Patient With Severe Left Ventricular Dysfunction

Presenter: Ali Ahmad

October 28, 2025

Presentation TCT 2025

TCT 850: The Continuous Saline Infusion Rate Required to Achieve Maximal Hyperaemia for Catheter-Based Measurements of Absolute Coronary Blood Flow and Microcirculatory Resistance in Severe Aortic Stenosis – The CORFLO-AS Validate Trial

Presenter: Harsh V. Thakkar

October 28, 2025

Presentation TCT 2025

TCT 1637: Percutaneous Coronary Intervention Complicated by Severe Symptomatic Coronary Spasm Associted With Tachycardia, Hypotension and VF: A Rare Case of Contrast Induced Kounis Syndrome

Presenter: Vipin Thomachan

October 28, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.